Z Gastroenterol 2011; 49 - P4_05
DOI: 10.1055/s-0030-1269660

A novel memory function of tolerant CD8+ T cells in anti-microbial immunity

J Böttcher 1, S Hegenbarth 1, D Stabenow 1, DH Busch 2, P van Endert 3, W Kolanus 4, C Kurts 1, JL Schultze 5, L Diehl 1, PA Knolle 1
  • 1Institute für Molekulare Medizin und Experimentelle Immunologie , Universität Bonn, Bonn
  • 2Institut für Medizinische Mikrobiologie, Immunologie und Hygiene, TU München, München
  • 3INSERM U580, Université Paris Descartes, Paris
  • 4Abteilung Molecular Immune & Cell Biology, LIMES Institut, Universität Bonn, Bonn
  • 5Abteilung Genomics and Immunoregulation, LIMES Institut, Universität Bonn, Bonn

Antigen-experienced memory T cells are defined by longevity and stem cell-like plasticity enabling them to give rise to effector T cells fighting microbial infection. It is believed that they arise from various stages of immunogenic T cell differentiation. Here, we provide evidence for a novel CD8+ T cell population (TL cells) that has memory function, but is generated under non-inflammatory conditions by antigen-presenting liver sinusoidal endothelial cells (LSEC) in vitro and in vivo. After efficient cross-presentation of soluble and gut-derived antigens by LSEC to naïve CD8+ T cells, antigen–experienced TL cells migrate to secondary lymphoid organs where they persist over long time in vivo. Transcriptome analysis by RNA-fingerprint revealed that TL cells have a unique transcriptional signature distinct from naïve, effector and conventional memory T cells. Furthermore, their RNA-fingerprint differs from the signatures of T cells that undergo deletional tolerance or are rendered anergic. In contrast to memory T cells generated during infection, TL cells lack direct cytotoxic T cell effector functions. However, in addition to an anatomical localisation reminiscent of central memory T cells, TL cells resist deletional cross-tolerance by dendritic cells and retain a high degree of plasticity after priming by LSEC in vivo. This allows TL cells to differentiate into protective effector T cells during viral and bacterial infections, which requires combinatorial CD28 and IL-12 signaling. Our results reveal a new pathway of memory T cell formation by liver-resident cells and will also allow deliberate exploitation of this functionally distinct cell population for vaccination.